TG THERAPEUTICS, INC. Income Taxes Paid
TG THERAPEUTICS, INC. (TGTX) reported Income Taxes Paid of $11.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-05
- TG THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2026-06-30 was $7.88M, a 55.19% increase year-over-year.
- TG THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2026-03-31 was $3.44M.
- TG THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2025-12-31 was $845.00K, a 69.00% increase year-over-year.
- TG THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2025-09-30 was $1.96M.
- TG THERAPEUTICS, INC. income taxes paid, net for fiscal 2025 was $7.88M, a 1475.80% increase from fiscal 2024.
- TG THERAPEUTICS, INC. income taxes paid, net for fiscal 2024 was $500.00K.
- TG THERAPEUTICS, INC. income taxes paid, net for fiscal 2023 was $0.00.
- TG THERAPEUTICS, INC. income taxes paid, net for fiscal 2022 was $0.00.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $11.32M 10-Q · filed 2026-08-05 | $12.16M derived: sum of 3 quarters · filed 2026-08-05 | $14.12M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $3.44M 10-Q · filed 2026-05-06 | $4.28M derived: sum of 2 quarters · filed 2026-05-06 | $6.24M derived: sum of 3 quarters · filed 2026-05-06 | $11.32M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $845.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.80M derived: sum of 2 quarters · filed 2026-02-27 | $7.88M derived: sum of 3 quarters · filed 2026-08-05 | $7.88M 10-K · filed 2026-02-27 |
| 2025-09-30 | $1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $7.03M derived: sum of 2 quarters · filed 2026-08-05 | $7.03M 10-Q · filed 2025-11-05 | $7.53M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $5.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.08M 10-Q · filed 2026-08-05 | $5.58M derived: sum of 3 quarters · filed 2026-08-05 | $5.58M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 | $500.00K derived: sum of 2 quarters · filed 2026-05-06 | $500.00K derived: sum of 3 quarters · filed 2026-05-06 | |
| 2024-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $500.00K derived: sum of 2 quarters · filed 2026-02-27 | $500.00K 10-K · filed 2026-02-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |